MiECC Versus Conventional Cardiopulmonary Bypass in Cardiac Surgery (MiECS)
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1300 participants.
Also called NCT05487612
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 1,300 participants
- Registry
-
NCT05487612
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Canada, Germany, Greece, Italy, Türkiye, United Kingdom
- Registry status
- Recruiting
Technical summary
Registry record NCT05487612. Randomized; single masking; primary purpose treatment. Start 2022-05-26 (actual); primary completion 2028-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- MiECC Versus Conventional Cardiopulmonary Bypass in Cardiac Surgery (MiECS)
- Acronym
- MiECS
- Condition
- Coronary Artery Disease
- Condition
- Aortic Valve Stenosis
- Condition
- Extracorporeal Circulation; Complications
- Intervention (Device)
- Minimal Invasive Extracorporeal Circulation
- Intervention (Device)
- Conventional cardiopulmonary bypass
- Lead sponsor
- Aristotle University Of Thessaloniki
- Collaborator
- Minimal Invasive Extracorporeal Technologies International Society (MiECTiS)
Record details
- Record id
cardio:ct-nct05487612- Content hash
27d4a7ffb4700d83e398915b41b6cd3d781701edf5cd1c0413fc76656957f175